VIR

Vir Biotechnology Inc.

Price

$9.77

return (12m)

124.08%

p/e

-6.07

p/bv

1.56

DIVIDEND YIELD

0.00%

VIR price

Vir Biotechnology

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment VIR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.17%

3 months

8.19%

1 year

124.08%

2 years

11.40%

5 years

-78.98%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals VIR

Valuation

P/E

-6.07

Sector -4.38

Industry -4.38

P/BV

1.56

Sector 2.02

Industry 2.02

P/Revenue (PSR)

5.05

Sector -4.40

Industry -4.40

EV/EBITDA

13.05

Sector -263.09

Industry -263.09

EV/EBIT

13.55

Sector -702.90

Industry -702.90

P/EBITDA

-5.69

Sector -4.39

Industry -4.39

P/EBIT

-5.45

Sector -4.73

Industry -4.73

P/Total Assets

1.26

Sector 1.49

Industry 1.49

P/Net Current Assets

4.48

Sector -11.70

Industry -11.70

P/Working Capital

3.19

Sector -3.19

Industry -3.19

EPS

-1.50

Sector -2.14

Industry -2.14

BVPS

5.85

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

99.99%

Sector 36.74%

Industry 36.74%

EBITDA Margin

31.92%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

30.75%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-92.59%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-83.17%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.20

Sector 0.03

Industry 0.03

Profitability

ROE

-25.62%

Sector -65.14%

Industry -65.14%

ROA

-20.72%

Sector -65.53%

Industry -65.53%

ROIC

50.48%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.04

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-6.98

Sector -6.07

Industry -6.07

Net Debt / EBIT

-7.25

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.54

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.81

Sector 0.41

Industry 0.41

Liabilities/Assets

0.19

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-22.57%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals VIR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
VIR Vir Biotechnology Inc.	$9.77	118.08%	0.00%	-6.07	1.56	-25.62%	-83.17%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

VIR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Vir Biotechnology

Vir Biotechnology Inc.

Average Investor10 user rating

4.0 (1 people)

United States

10 years

Founded: 2016

2019

Time since IPO - 7 years

327

Employees

Vir Biotechnology Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.53 billion, with shareholders equity totaling $982.49 million.

The company employs approximately 327 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Vir Biotechnology Inc. reported $302.60 million in revenue, generating net income of $-251.67 million.

Key financial metrics include a P/E ratio of -6.07, a price-to-book (P/B) ratio of 1.56, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker VIR.

Market cap

$1.53 billion

Net worth

$982.49 million

$982,490,000.00

Assets

$1.21 billion

$1,214,810,000.00

Total Shares Outstanding

168.00 million

168,000,000

Average Daily Trading Volume

$1.86 million

$1,858,788.00

Sector

Health Care

Industry

Biotechnology

VIR

VIR revenue and profits

Financial Results VIR

DRAG THE FRAME TO SEE MORE DATA

VIR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Vir Biotechnology (VIR) today?

A cotação de Vir Biotechnology (VIR) hoje está em US$ 9.77, com uma variação de 124.08% em relação ao último ano. A cotação de Vir Biotechnology (VIR) iniciou o ano negociando na casa dos US$ 6.03 e hoje está em US$ 9.77. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Vir Biotechnology (VIR) e dados de ações do Ibovespa e mercados internacionais.

Quando Vir Biotechnology (VIR) paga dividendos?

Vir Biotechnology (VIR) não distribuiu dividendos no último ano.

Is Vir Biotechnology (VIR) a good investment?

Atualmente, Vir Biotechnology (VIR) está cotada a US$ 9.77, com um P/L de -6.07, representando um desvio de -110% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 124.08 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 124.08%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Vir Biotechnology (VIR) stock?

Investir em ações de Vir Biotechnology (VIR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Vir Biotechnology (VIR) yield today?

A rentabilidade de Vir Biotechnology (VIR) foi de 3.17% no último mês, 124.08% no último ano e -78.98% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Vir Biotechnology (VIR) hoje, o investimento total seria de US$ 977.00, com base na cotação atual de US$ 9.77.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,189.26
Em 5 anos: US$ 205.37
Em 10 anos: US$ 977.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

VIR

Vir Biotechnology Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment VIR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING VIR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Vir Biotechnology

Vir Biotechnology Inc.

United States

10 years

2019

327

PROFIT X PRICE VIR

Financial Results VIR

VIR cash flow

Asset, Revenue and Profit Growth - VIR

VIR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions